Evaluation and Management of Sore Nipple in Adults
A sore nipple in an adult requires immediate differentiation between dermatologic conditions (eczema, irritant dermatitis, infection) and pathologic nipple discharge with underlying breast pathology—the latter carrying up to 21% malignancy risk and demanding urgent imaging evaluation. 1, 2
Initial Clinical Assessment
Determine if nipple discharge is present:
Critical Red Flags Requiring Urgent Evaluation
The following features mandate immediate imaging and possible biopsy to exclude malignancy:
- Unilateral persistent nipple lesion with erythema, erosion, or crusting—must exclude Paget's disease (found in >80% of cases with underlying breast cancer) 7
- Pathologic nipple discharge with palpable mass (61.5% malignancy risk vs 6.1% without mass) 2
- Male patient with nipple symptoms (23-57% malignancy rate) 2, 3
- Age >60 years with pathologic discharge (32% malignancy rate) 2
- Acquired nipple inversion 8, 7
Imaging Algorithm for Pathologic Discharge or Suspicious Lesions
For patients ≥40 years:
- Start with diagnostic mammography or digital breast tomosynthesis (DBT) plus ultrasound 1, 2, 3
- Sensitivity 15-68% for mammography, 63-100% for ultrasound in detecting intraductal lesions 1, 2
For patients 30-39 years:
For patients <30 years:
If initial imaging is negative but pathologic discharge persists:
- Consider breast MRI (sensitivity 86-100% for detecting causes of pathologic discharge) 1, 2
- MRI particularly useful when mammography and ultrasound are negative 1
Management of Dermatologic Causes
For eczematous/inflammatory nipple conditions:
- First-line treatment: topical corticosteroids or calcineurin inhibitors (both safe during lactation) 5
- Identify and eliminate provoking factors: repetitive friction, chemical irritants, allergens 5
- Intensive moisturization with emollient wash products 5
- Warm water or black tea compresses for symptom relief 5
Common pitfall: Persistent unilateral nipple eczema that fails to respond to standard treatment within 2-3 weeks requires biopsy to exclude Paget's disease 7
When to Obtain Tissue Diagnosis
Image-guided core needle biopsy (preferred over FNA) is indicated for:
- Any BI-RADS category 4 or 5 lesion identified on imaging 1, 3
- Persistent unilateral nipple skin changes despite dermatologic treatment 7
- Suspicious intraductal lesions detected on ultrasound or MRI 1
Surgical duct excision is reserved for:
- Persistent pathologic discharge with negative imaging studies 1, 3
- Not indicated for physiologic discharge or routine dermatologic conditions 4, 3
Management Based on Discharge Characteristics
Physiologic discharge (bilateral, non-spontaneous, milky/green/yellow):
- No imaging needed if screening mammography is current 1, 4, 2
- Patient education: stop breast compression/manipulation 3
- Instruct patient to report any change to spontaneous, unilateral, or bloody discharge 4, 3
Pathologic discharge:
- Proceed with age-appropriate imaging algorithm as outlined above 1, 2
- Overall cancer risk 5-21%, with 10% at age 40 and 32% after age 60 1, 2
Special Populations
Lactating women:
- Topical corticosteroids and calcineurin inhibitors are safe 5
- Adjust latch/positioning during breastfeeding 5
- Consider nipple protection devices 5
- Ductography is contraindicated during active lactation 1
Male patients:
- Any nipple discharge in males warrants full imaging evaluation (57% malignancy rate in one study) 4, 2
- Ultrasound equally useful for lesion identification and biopsy guidance 1
Transgender patients on estradiol:
- Clear bilateral discharge requiring manual expression is physiologic 3
- No imaging needed unless discharge becomes spontaneous, unilateral, or bloody 3
Key Clinical Pearls
- Never dismiss persistent unilateral nipple changes as simple dermatitis—always consider Paget's disease 7
- Ultrasound and mammography are unreliable in predicting histologic diagnosis; tissue diagnosis is essential for image-detected lesions 1
- Most pathologic discharge is due to benign intraductal papilloma (35-48%), but 5-21% is malignant 2
- If dermatologic treatment fails within 2-3 weeks or symptoms worsen, refer for dermatology evaluation and consider biopsy 9, 7